A recent study showed that local delivery of IGF-I in a hydrogel injected into the stroke cavity, providing sustained IGF-I release to the peri-infarct cortex for a period of up to 4 weeks, does not induce changes in cortical connections compared to vehicle treated stroke controls9. This evidence concerns the gene IGF1 and stroke disorder.